ANDA 88521, held by Smith And Nephew. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 88521 (Phenytoin Sodium), held by Smith And Nephew, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Phenytoin Sodium50MG/ML ยท injectable;injection | Phenytoin Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters